GANX
Gain Therapeutics Inc.
Company Overview
| Mkt Cap | $56.80M | Price | $1.96 |
| Volume | 1.14M | Change | +11.36% |
| P/E Ratio | -2.8 | Open | $1.80 |
| Revenue | -- | Prev Close | $1.76 |
| Net Income | $-20.4M | 52W Range | $1.41 - $2.81 |
| Div Yield | N/A | Target | $7.43 |
| Overall | 54 | Value | 40 |
| Quality | 31 | Technical | 91 |
No chart data available
Stock Overview
Updated DailyGain Therapeutics Inc. (GANX) is a leading Manufacturing company in the Pharmaceutical Preparation Manufacturing industry, currently trading at $1.96 with a market capitalization of $56.80 million. The stock is in the lower portion of its trading range, demonstrating concerning quality fundamentals with a MarketXLS quality score of 31.
Today's trading session shows GANX with a volume of 1.14 million shares. The stock opened up 2.27% from yesterday's close of $1.76. Current analyst estimates project earnings of $-0.67 per share for this year, with next year targeting $-0.73.
GANX demonstrates very strong technical momentum based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for GANX include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 279.1%. The stock shows elevated valuation levels based on valuation analysis.
Analysis generated on November 3, 2025 at 12:30 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GANX | $1.96 | +11.4% | 1.14M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |